Michał Zientara

Over 5 years of experience in the clinical trials industry as a CRA with both Pharma and CRO companies.

Therapeutic area experience:

Phase III: Respiratory – Chronic Obstructive Pulmonary Disease (3 studies)

Phase III: Cardiovascular – Heart Failure rEF (2 studies), pEF (1 study)

Phase III: Neurology – Multiple Sclerosis (1 study)

Phase III: Ophthalmology – Choroidal neovascularization (1 study)

Phase III: Rheumatology – Ankylosing Spondylitis (1 study)

Phase II: Neurology – Multiple Sclerosis (1 study)

Phase II: Rheumatology – Rheumatoid Arthritis (1 study)

Local lead CRA in rheumatoid arthritis, multiple sclerosis and ankylosing spondylitis studies.

Unblinded CRA in COPD, psoriasis and gout studies.